trending Market Intelligence /marketintelligence/en/news-insights/trending/QnZkEcNcZqEK4puJAgY7lA2 content esgSubNav
In This List

Frazier Healthcare Partners pulls in over $617M for latest life sciences fund

Podcast

Street Talk | Episode 98: Regulatory scrutiny having cooling effect on community bank M&A

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Podcast

Street Talk | Episode 97: Recessionary fears still keeping bank investors on the sidelines

Blog

Making sanctions effective: Key themes for banks


Frazier Healthcare Partners pulls in over $617M for latest life sciences fund

Frazier Healthcare Partners, or Frazier Management LLC, raised over $617 million for Frazier Life Sciences X LP.

The oversubscribed fund will mainly target therapeutics-focused companies that develop and commercialize biopharmaceuticals.

It will invest in company creation, early-stage venture and late-stage private or public opportunities, with two-thirds of its capital to be allocated in seed and series A financing rounds.